TOCQUEVILLE ASSET MANAGEMENT L.P. - KYTHERA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$8,991,000
-54.5%
119,912
-54.3%
0.12%
-48.5%
Q2 2015$19,772,000
+32.0%
262,547
-12.1%
0.23%
+32.4%
Q1 2015$14,975,000
+49.1%
298,599
+3.1%
0.18%
+63.0%
Q4 2014$10,043,000
+207.9%
289,594
+190.8%
0.11%
+200.0%
Q3 2014$3,262,000
-9.1%
99,585
+6.5%
0.04%
+2.9%
Q2 2014$3,587,000
+59.5%
93,490
+65.3%
0.04%
+16.7%
Q1 2014$2,249,000
+24.9%
56,570
+17.3%
0.03%
+25.0%
Q4 2013$1,801,00048,2200.02%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
AlpInvest Partners B.V. 33,271$1,277,0004.55%
Palo Alto Investors LP 949,959$36,450,0002.71%
Redmile Group, LLC 560,356$21,501,0002.61%
SENZAR ASSET MANAGEMENT, LLC 124,900$4,792,0001.83%
Aureus Asset Management, LLC 152,662$5,858,0001.46%
PFM Health Sciences, LP 952,715$36,556,0000.73%
REGENTATLANTIC CAPITAL LLC 176,454$6,771,0000.63%
Polar Capital LLP 519,398$19,927,0000.42%
FNY Managed Accounts LLC 2,500$95,925,0000.35%
Partner Investment Management, L.P. 36,173$1,388,0000.28%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders